Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for hair loss and ABS-301 for solid tumors offer additional sizeable TAMs if successful. ABSI’s AI models and wet lab ...

(RTTNews) - Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to ...

In this article, we are going to take a look at where Absci (NASDAQ:ABSI) stands against other AI companies under $2 billion market cap. It’s clear that AI holds immense promise but it comes ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often ...

Wellington Management Group LLP raised its stake in Absci Co. (NASDAQ:ABSI – Free Report) by 44.8% in the third quarter, according to the company in its most recent disclosure with the ...

The rapid growth of artificial intelligence/machine learning (AI/ML ... aligning well with its AI/ML-driven platform. Price Action: ABSI stock is up 23% at $3.96 at the last check on Wednesday.

The firm increased its portfolio allocation in ABSI by 45.17% over the last quarter. Fred Alger Management holds 7,567K shares representing 6.59% ownership of the company. In its prior filing ...